نتایج جستجو برای: monotherapy hematopoietic

تعداد نتایج: 73323  

2012
Magnus Gisslén Dietmar Fuchs Lars Hagberg Bo Svennerholm Henrik Zetterberg

Darunavir/ritonavir monotherapy maintains HIV suppression in most patients who have achieved an undetectable viral load on combination antiretroviral treatment, and is increasingly used in the clinic. However, concerns have been raised about the effectiveness of ritonavir-boosted protease inhibitor (PI/r) monotherapy in the prevention of HIV replication in the central nervous system (CNS). Here...

Journal: :PharmacoEconomics 2000
J A Paladino L D Fong A Forrest R Ramphal

OBJECTIVE To assess the relative cost effectiveness of cephalosporin monotherapy options and aminoglycoside/ureidopenicillin combination therapy for the treatment of febrile episodes in adult patients with neutropenia. DESIGN AND SETTING This was a retrospective cost-effectiveness analysis conducted from the institutional perspective. METHODS The analysis was based on 741 febrile episodes i...

2012
Wenyu Ye Haya Ascher-Svanum Jennifer A Flynn Yuka Tanji Michihiro Takahashi

PURPOSE Although expert guidelines for the treatment of schizophrenia recommend antipsychotic monotherapy, the use of antipsychotic polypharmacy is common. This study identified characteristics that differentiate patients with schizophrenia who are treated with olanzapine monotherapy versus polypharmacy in usual care in Japan. PATIENTS AND METHODS In a large (N = 1850) prospective, observatio...

Journal: :Seizure 2004
MICHAEL E NEWMARK STEPHANIE DUBINSKY

OBJECTIVE Reports on zonisamide monotherapy are limited despite favourable preliminary data, and typically restricted to tertiary referral centres. The goal of this study is to report clinical experience with zonisamide monotherapy in a large, multi-group clinic setting. METHODS We reviewed the charts of patients treated with zonisamide monotherapy in the Neurology Department of the Kelsey-Se...

Journal: :iranian journal of medical sciences 0
saeid shahrabi department of hematology, faculty of medical sciences, tarbiat modares university, tehran, iran saeid kaviani department of hematology, faculty of medical sciences, tarbiat modares university, tehran, iran; and department of immunology, faculty of medical sciences, tarbiat modares university, tehran, iran masoud soleimani department of hematology, faculty of medical sciences, tarbiat modares university, tehran, iran; and department of immunology, faculty of medical sciences, tarbiat modares university, tehran, iran ali akbar pourfathollah department of immunology, faculty of medical sciences, tarbiat modares university, tehran, iran behnaz bakhshandeh department of biotechnology, college of science, university of tehran, tehran, iran saeideh hajizamani diagnostic laboratory sciences and technology research center, school of paramedical sciences, shiraz university of medical sciences, shiraz, iran

background: human umbilical cord blood (hucb) is an acceptable and readily accessible source of stem cells. there is an ongoing interest in cord blood stem cell therapies; however, little is known about the possible unfavorable effects of laboratory modifications on the isolated hucb cells. the involvement of mirnas in several biological processes has been shown. the aim of this study was to ev...

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad faizan zahid medical college, the aga khan university, karachi, pakistan. natasha ali departments of pathology & microbiology and oncology, the aga khan university, karachi, pakistan. mohammad usman shaikh departments of pathology & microbiology and oncology, the aga khan university, karachi, pakistan. salman naseem adil departments of pathology & microbiology and oncology, the aga khan university, karachi, pakistan.

introduction: allogeneic hematopoietic stem cell transplantation is a potentially curative treatment modality for hematological malignancies. we evaluated the outcome of patients suffering from hematological malignancies, including acute leukemias, chronic myeloid leukemia and myelodysplastic syndrome after allogeneic transplantation. methods: all patients having hematological malignancies with...

Journal: :iranian journal of pharmaceutical research 0
maria tavakoli affiliation mahdi tabarraee hematology and oncology center, taleghani hospital, shahid beheshti university of medical sciences, tehran, iran mahshid mehdizadeh taleghani bone marrow transplantation center, taleghani hospital, shahid beheshti university of medical sciences, evin, tehran, iran. abbas hajifathali taleghani bone marrow transplantation center, taleghani hospital, shahid beheshti university of medical sciences, evin, tehran, iran. mojtaba ghadiany hematology and oncology center, taleghani hospital, shahid beheshti university of medical sciences, tehran, iran hmid rezvani hematology and oncology center, taleghani hospital, shahid beheshti university of medical sciences, tehran, iran

background: antibiotic prophylaxis is usually used in allogenic stem cell transplantation, but its use in autologous stem cell transplantation (asct) is controversial. we evaluated the efficacy of ciprofloxacin prophylaxis in asct. materials and methods: to identify the efficacy of ciprofloxacin on the incidence of neutropenic fever and its complications, 72 patients had been admitted to talegh...

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad vaezi hematologist- oncologist, hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran cyrous gharib hematologist- oncologist, gilan university of medical sciences, gilan, iran maryam souri 3hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh professor of medicine, hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

background: hematopoietic stem cell transplantation (hsct) is currently the only curative treatment for acute leukemia. as hsct improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following hsct. subjects and methods: the study included 122 patients (65 male, 57 female) with leukemia (72 aml and 50 all) who received transplants f...

Journal: :international journal of hematology-oncology and stem cell research 0
mahdi jalili hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir ali hamidieh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hamdi hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mohammad jahani hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran babak bahar hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

introduction: severe acquired aplastic anemia (saa) is a rare disease and matched related hematopoietic stem cell transplantation (hsct) is the treatment of choice especially in pediatric patients. immunosuppressive therapy is the alternative treatment in patients who do not have a donor. we retrospectively analyzed patients who received allogeneic hsct at our institution. methods: between 1991...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: acute myelogenous leukemia (aml) is a clonal  malignant disease of hematopoietic tissue. the early use of  hematopoietic stem cell transplantation (hsct) for aml was for patients with advanced stages of disease, usually while in relapse, in second or subsequent remission, or with resistant disease. patients and methods: from march 1991 until february 2008, 356(65%) registered allo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید